Logo
Apparel & Fashion

Description

D. L. Tetramizole represents a premium active pharmaceutical ingredient manufactured in FDA-approved facilities in Mumbai, India. With manufacturing expertise dating back to 1971, this bulk API consistently meets international pharmacopeial standards including IP, BP, EP, and USP specifications. The product undergoes rigorous quality control testing to ensure purity, potency, and safety for medicinal applications. Ready stock availability guarantees timely supply chain fulfillment for pharmaceutical companies requiring reliable API sourcing. Comprehensive documentation and regulatory compliance support facilitate seamless integration into manufacturing processes for global clients.

The pharmaceutical industry extensively utilizes D. L. Tetramizole in manufacturing anthelmintic preparations for human and veterinary healthcare sectors. Human pharmaceutical applications include tablet formulations for treating parasitic worm infections in gastrointestinal disorders across different age g...
D. L. Tetramizole represents a premium active pharmaceutical ingredient manufactured in FDA-approved facilities in Mumbai, India. With manufacturing expertise dating back to 1971, this bulk API consistently meets international pharmacopeial standards including IP, BP, EP, and USP specifications. The product undergoes rigorous quality control testing to ensure purity, potency, and safety for medicinal applications. Ready stock availability guarantees timely supply chain fulfillment for pharmaceutical companies requiring reliable API sourcing. Comprehensive documentation and regulatory compliance support facilitate seamless integration into manufacturing processes for global clients.

The pharmaceutical industry extensively utilizes D. L. Tetramizole in manufacturing anthelmintic preparations for human and veterinary healthcare sectors. Human pharmaceutical applications include tablet formulations for treating parasitic worm infections in gastrointestinal disorders across different age groups. Veterinary medicine manufacturers incorporate this API in deworming injections, oral suspensions, and feed additives for livestock, poultry, and companion animals. Export-oriented pharmaceutical companies rely on consistent quality for manufacturing products destined for regulated markets worldwide. The injectable grade serves hospital and clinical settings where immediate therapeutic intervention is required for severe parasitic infections.

Businesses choosing D. L. Tetramizole gain competitive advantage through assured supply chain reliability and technical support. The established track record since 1971 demonstrates long-term commitment to quality and customer satisfaction. FDA-approved manufacturing ensures compliance with international regulatory requirements, reducing approval timelines for finished product manufacturers. Bulk quantity availability with consistent quality makes it the preferred choice for pharmaceutical companies seeking dependable API sourcing relationships. The product's reliability across multiple pharmacopeial standards provides peace of mind for manufacturers producing critical healthcare medications.

Key Features:
- Complies with IP, BP, EP, USP, and injectable grade standards
- Manufactured in FDA-approved facility in Mumbai, India
- Available for immediate dispatch from ready stock
- Consistent purity and potency across batches
- Comprehensive quality documentation and regulatory support

Benefits:
- Ensures regulatory compliance for global market access
- Reduces manufacturing risks with consistent API quality
- Minimizes supply chain disruptions with ready availability
- Accelerates product development with reliable documentation
- Supports diverse formulation needs across therapeutic applications

Specifications

Additional Information
Country of OriginIndia

Application

D. L. Tetramizole API serves as a broad-spectrum anthelmintic compound for pharmaceutical formulations targeting parasitic infections. Its versatility allows integration into multiple drug delivery systems including oral tablets, injectable solutions, and liquid suspensions for both human and animal therapeutic applications. The API meets stringent international pharmacopeial standards ensuring consistent performance across different treatment protocols and patient demographics. Manufacturers value this API for its proven efficacy against gastrointestinal parasites and reliable safety profile. The injectable grade enables rapid therapeutic intervention in clinical settings while oral formulations provide convenient treatment options for outpatient care. Consistent batch-to-batch quality makes it suitable for large-scale production of deworming medications across diverse healthcare segments. - Human pharmaceutical tablets for intestinal parasite treatment - Veterinary injectable solutions for livestock deworming programs - Pediatric suspension formulations for parasite control - Animal health products for poultry and swine industries - Export-quality medications for international pharmaceutical markets

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

A. S. Joshi & Company, Maharashtra
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler•Importer / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

D. L. Tetramizole API Bulk IP BP EP USP Injectable Anthelmintic

D. L. Tetramizole API bulk IP BP EP USP injectable anthelmintic from FDA-approved Mumbai manufacturer. Used in human and veterinary deworming medications with reliable supply since 1971 for pharmaceutical companies.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

A. S. Joshi & Company
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler

More Products From Supplier